Pharmacokinetics and Bioequivalence of Domestic Zolmitriptan Tablets in Chinese Healthy Volunteers
Rui WANG,Yi FANG,Fei PEI,Dong CHAI,Kun CHEN,Bei-bei LIANG,Jian-zhong QIAO,Gui-lan YUAN,Liang XU,Zhen-qing ZHANG
DOI: https://doi.org/10.3321/j.issn:1001-2494.2007.03.013
2007-01-01
Abstract:OBJECTIVE: To study pharmacokinetics and bioequivalence of domestic and imported zolmitriptan tablets in Chinese healthy volunteers. METHODS: A single oral dose of 7.5 mg domestic and imported zolmitriptan tablets was given to 24 healthy volunteers in a randomized cross-over study. The concentrations of zolmitriptan in human plasma were determined by HPLC and the pharmacokinetic parameters were calculated by 3P97 software. RESULTS: The concentration-time curves of zolmitriptan in plasma were fitted with a two compartment model after an oral single dose. The main pharmacokinetic parameters of domestic and imported tablet were as follows: tmax (2.48 ± 0.40) and (2.50 ± 0.36) h , ρmax (13.22 ± 2.55) and (13.06 ± 3.24) μg·L-1, AUC0-t, (59. 52 ± 19.99) and (63.60 ± 17.98) μg·h·L-1, t 1/2ke(2.16 ± 0.62) and (2.31 ± 0.50) h, respectively. The relative bioavailability of zolmitriptan was (94.8 ± 13. 0)%. Statistical analysis showed that domestic and imported zolmitriptan were bioequivalent, the 90% confidence interval of AUC0-t and ρmax were 89.1 % - 97.7% and 94.9% -111.0%, respectively. CONCLUSION: The domestic and imported zolmitriptan tablets are bioequivalent.